Casandra
Casandra Test Code QD54163Version 1 (DRAFT)
Performing Lab
Neisseria gonorrhoeae RNA, TMA, Urogenital
Also known as: NG TMA, GC Aptima, Hologic, GC TMA, NG Aptima
Clinical Use
Order TestUse
Intended for qualitative detection of Neisseria gonorrhoeae via transcription-mediated amplification (TMA) of rRNA from urogenital specimens. Useful for diagnosis in symptomatic or screening contexts in accord with CDC recommendations.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
NGS
Biomarkers
Uses transcription‑mediated amplification (TMA), a nucleic acid amplification method, to qualitatively detect Neisseria gonorrhoeae RNA in urogenital specimens.
NGS Component
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Urine
Volume
Not provided
Minimum Volume
Not provided
Related Tests
Other tests from different labs that may be relevant
Neisseria gonorrhoeae by Transcription-Mediated Amplification (TMA)
ARUP Laboratories
Neisseria gonorrhoeae (TMA)
MPLN
Chlamydia trachomatis and Neisseria gonorrhoeae (CTNG) by Transcription-Mediated Amplification (TMA) with Reflex to CT/NG Confirmation
ARUP Laboratories
Chlamydia trachomatis and Neisseria gonorrhoeae by Transcription-Mediated Amplification (TMA)
ARUP Laboratories
Neisseria gonorrhoeae, Nucleic Acid Amplification, Varies
Mayo Clinic Lab
Chlamydia trachomatis/Neisseria gonorrhoeae (TMA)
MPLN
Chlamydia/Gonococcus, NAA With Confirmation
Labcorp
Neisseria gonorrhoeae, NAA
Labcorp
Chlamydia/Gonococcus/Mycoplasma genitalium, NAA, Urine
Labcorp
Sexually Transmitted Disease Panel 1 by Transcription-Mediated Amplification
ARUP Laboratories